drugset / Trial / NCT03719560
Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
Phase 2 single-institution trial of early systemic central nervous system prophylaxis in high-risk diffuse large B-cell lymphoma
Timeline
- Start
- 2019-07-01
- Primary completion
- 2022-12-31
- Completion
- 2025-12-31
Outcome
Outcome not reported
Stopped (Business): “lack of funding”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cytarabine | Small molecule | — | — |
| Subject | Methotrexate | Small molecule | — | — |